Annotated compound libraries have emerged as an interesting phenomenon in drug discovery in the post-genomic era. The underlying strategy behind selection of these biased libraries is to bring together information pertaining to the relationships between biological targets, respective small-molecule ligands and their biological functions in a single knowledge-management platform. In this review, we comment on several technologies based on annotated libraries launched in 2003–2006 and their implications for pharmaceutical screening.